Gastric cancer with para-aortic lymph nodes metastasis: curable dissection possible but be cautiously selected
- PMID: 25023488
- DOI: 10.1007/s00280-014-2512-y
Gastric cancer with para-aortic lymph nodes metastasis: curable dissection possible but be cautiously selected
Abstract
This is a reply letter to Dr. M Daniele et al. entitled as "gastric cancer with para-aortic lymph nodes metastasis: do not miss a chance of cure!". Para-aortic lymph node metastasis has been regarded as a pattern of distant metastasis in gastric cancer. Even patients with PAN metastasis undergo extensive lymph nodes, the prognosis is unsatisfactory and the overall survival is not better than the patients receiving palliative chemotherapy. However, for the patients who were responded to the preoperative chemotherapy, subsequent radical gastrectomy performed prolonged survival. Meanwhile, patients who were resistant to the previous chemotherapy were not optimal candidates for curative resection in advanced gastric cancer patients with PAN metastasis. How large with lymph nodes dissection for the patients with initially PAN metastasis after effective neo-chemotherapy is still a controversial issue and needs further large-scale randomized trials.
Comment on
-
A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis.Cancer Chemother Pharmacol. 2014 Jun;73(6):1155-61. doi: 10.1007/s00280-014-2449-1. Epub 2014 Apr 21. Cancer Chemother Pharmacol. 2014. PMID: 24748418 Free PMC article. Clinical Trial.
-
Gastric cancer with para-aortic lymph node metastases: do not miss a chance of cure!Cancer Chemother Pharmacol. 2014 Aug;74(2):433-4. doi: 10.1007/s00280-014-2491-z. Epub 2014 Jun 3. Cancer Chemother Pharmacol. 2014. PMID: 24889718
Similar articles
-
Gastric cancer with para-aortic lymph node metastases: do not miss a chance of cure!Cancer Chemother Pharmacol. 2014 Aug;74(2):433-4. doi: 10.1007/s00280-014-2491-z. Epub 2014 Jun 3. Cancer Chemother Pharmacol. 2014. PMID: 24889718
-
Candidates for curative resection in advanced gastric cancer patients who had equivocal para-aortic lymph node metastasis on computed tomographic scan.Ann Surg Oncol. 2006 Sep;13(9):1163-7. doi: 10.1245/s10434-006-9002-3. Epub 2006 Sep 3. Ann Surg Oncol. 2006. PMID: 16952027
-
A phase II study of perioperative treatment in gastric cancer with No.16a2/b1 lymph node metastasis: DRAGON-06 trial.Future Oncol. 2022 Dec;18(39):4239-4349. doi: 10.2217/fon-2022-0718. Epub 2023 Jan 18. Future Oncol. 2022. PMID: 36651765
-
[Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Oct 25;21(10):1087-1092. Zhonghua Wei Chang Wai Ke Za Zhi. 2018. PMID: 30370504 Review. Chinese.
-
Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?Surg Today. 2015 Sep;45(9):1082-90. doi: 10.1007/s00595-014-1067-1. Epub 2014 Nov 1. Surg Today. 2015. PMID: 25366353 Review.
Cited by
-
Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX).Oncotarget. 2016 Nov 15;7(46):76298-76307. doi: 10.18632/oncotarget.11818. Oncotarget. 2016. PMID: 27602586 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical